CALC
CalciMedica, Inc. (CALC) Risks & Opportunities Analysis (2026)
No material changes this month.
Risks
Negative interest coverage and sub-1.0 net debt/EBITDA indicate limited earnings cushion, leaving CALC more exposed than peers with positive coverage if demand or pricing softens.
Extremely elevated payables and a distorted cash conversion cycle suggest working-capital dependence on supplier terms, which can constrain flexibility versus peers with cleaner cash generation.
High current and quick ratios imply ample liquidity, but they also signal balance-sheet conservatism that may lag more efficient peers in converting capital into growth.
With no reported FCF margin, visibility into cash durability is weaker than for peers with disclosed free-cash-flow conversion, increasing uncertainty around reinvestment capacity.
If industry demand normalizes or competitive pricing intensifies, CALC’s modest leverage headroom could translate into less resilience than stronger-capitalized peers.
Opportunities
Strong liquidity ratios provide substantial near-term operating flexibility, positioning CALC better than more levered peers to absorb volatility and fund working-capital needs.
Net debt to EBITDA below 1.0 suggests manageable leverage, giving CALC more room than highly indebted peers to support growth or withstand cyclical pressure.
The unusually favorable cash conversion profile, even if partly driven by payables, indicates strong working-capital leverage that can support cash preservation versus peers.
Low leverage combined with high liquidity can improve strategic optionality relative to peers, especially if end-market demand strengthens and capital deployment opportunities emerge.
Overall Score
CALC’s strong liquidity and low leverage support peer-relative resilience, while weak interest coverage and working-capital dependence temper the outlook versus stronger cash-conversion peers.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on CalciMedica, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
